FDA approves supplemental test for Chagas disease in blood

11/22/2011 | Medscape (free registration)

The FDA has approved Abbott Laboratories' ESA Chagas assay, which can identify antibodies to Trypanosoma cruzi, the parasite that causes Chagas disease, in human serum and plasma samples. The FDA said the test is the first licensed as a supplemental test for the disease.

View Full Article in:

Medscape (free registration)

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA
Food Lawyer
Cargill
Wayzata, MN
Director of Clinical Research
Regenesis Biomedical, Inc.
Scottsdale, AZ
Actuary
Meridian Health Plan
Detroit, MI
Assistant Vice President - Dental Director
MetLife
Bridgewater, NJ